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To study the pathogenesis of chronic wasting disease (CWD) in deer and elk, transgenic (tg) mice were generated that expressed the prion
protein (PrP) of deer containing a glycine at amino acid (aa) 96 and a serine at aa 225 under transcriptional control of the murine PrP promoter.
This construct was introduced into murine PrP-deficient mice. As anticipated, neither non-tg mice nor PrP ko mice were susceptible when
inoculated intracerebrally (i.c.) or orally with CWD brain material (scrapie pool from six mule deer) and followed for 600+ days (dpi). Deer PrP tg
mice were not susceptible to i.c. inoculation with murine scrapie. In contrast, a fatal neurologic disease occurred accompanied by conversion of
deer PrPsen to PrPres by western blot and immunohistochemistry after either i.c. inoculation with CWD brain into two lines of tg mice studied
(312+32 dpi [mean+2 standard errors] for the heterozygous tg line 33, 275+46 dpi for the heterozygous tg line 39 and 210 dpi for the
homozygous tg line 33) or after oral inoculation (381+55 dpi for the homozygous tg line 33 and 370+26 dpi for the homozygous tg line 39).
Kinetically, following oral inoculation of CWD brain, PrPres was observed by day 200 when mice were clinically healthy in the posterior surface
of the dorsum of the tongue primarily in serous and mucous glands, in the intestines, in large cells at the splenic marginal zone that anatomically
resembled follicular dendritic cells and macrophages and in the olfactory bulb and brain stem but did not occur in the cerebellum, cerebral cortex
or hippocampus or in hearts, lungs and livers of infected mice. After 350 days when mice become clinically ill the cerebellum, cerebral cortex and
hippocampus became positive for PrPres and displayed massive spongiosis, neuronal drop out, gliosis and florid plaques.
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Transmissible spongiform encephalopathies (TSE, scrapie or
prion) are a group of rare uniformly fatal neurodegenerative
diseases of humans and animals (Chesebro, 1999; Prusiner,
2001). Prion diseases occur in various mammalian species,
including humans with Kuru and Creutzfeldt-Jakob disease
(CJD), cattle with bovine spongiform encephalopathy (BSE) or
“mad cow disease”, sheep with scrapie and deer and elk with
chronic wasting disease (CWD). Disease is associated with the⁎ Corresponding author. Viral-Immunobiology Laboratory, Molecular and
Integrative Neurosciences Department, The Scripps Research Institute, 10550
N. Torrey Pines Road, La Jolla, CA 92037, USA. Fax: +1 858 784 9981.
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doi:10.1016/j.virol.2007.03.032conversion of the normal host PrP (PrPsen) found inmost cells to
abnormally folded beta sheath enriched protease resistant
isoform PrPres (PrPsc). Although prion diseases dramatically
damage the central nervous system (CNS), infection as well as
the protein PrPres can be detected within peripheral tissues,
including lymphoid organs (Bosque et al., 2002; Chesebro,
1999; Peden et al., 2006; Prusiner, 2001), skeletal muscle
(Angers et al., 2006; Bosque et al., 2002; Peden et al., 2006),
tongue, oral and nasal mucosa (DeJoia et al., 2006; Mulcahy
et al., 2004), kidney,1 pancreas1 (Heikenwalder et al., 2005),
intestine1, blood and heart (Aguzzi and Glatzel, 2006; Hewitt
et al., 2006; Houston et al., 2000; Jewell et al., 2006; Trifilo et al.,
2006).1 Trifilo, M., Oldstone, M.B.A., 2005. Unpublished observations, manuscript
in preparation.
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concern (Medicine, 2004). Deer raised on farms and in the wild
have CWD. Spread of CWD from one infected deer to others in
holding pens strongly suggests horizontal transmission of the
disease. This is supported by the recent detection of infectious
transmissible material in deer saliva (Mathiason et al., 2006).
Although there is a species barrier that usually prevents passage
of scrapie from one species to another, it is currently unknown
whether CWD in deer and elk is transmissible to humans.
Concern about this possibility stems from three observations.
First, experimental results indicate that human PrPsen converts
to human PrPres in vitro in the presence of CWD PrPres
(Caughey, 2001; Caughey and Chesebro, 2001). Although
conversion is of low efficiency, it is in the range observed when
human PrPsen is changed to human PrPres in the presence of
BSE PrPres, and BSE has been transmitted to humans
(reviewed, Aguzzi and Glatzel, 2006; Chesebro, 1999;
Prusiner, 1999). Second, CWD has been transmitted to non-
human primates (Marsh et al., 2005). Third, saliva and blood
from deer with CWD produced disease after inoculation into
uninfected deer hosts (Mathiason et al., 2006), demonstrating
that materials which come in contact with humans harbor the
infection. However, there is as yet no evidence that CWD can
transmit disease to humans as tg mice expressing human PrP
fail to develop disease when given deer/elk scrapie (Kong
et al., 2005) and public health surveillance of humans in
contact with deer has not revealed transmission of disease
(Medicine, 2004).
CWD was identified in the late 1960s among captive
mule deer at a Colorado research facility and designated as a
TSE disease that affects white tailed and mule deer as well
as elk (Williams and Young, 1980, 1982). CWD bears many
similarities to other TSE diseases, e.g., unremitting neurolo-
gic disease with PrPres accumulation, neuronal loss, wide-
spread spongiform formation and gliosis within the CNS,
and presence of PrPres in follicular dendritic cells in the
spleen. CWD, scrapie in sheep and human vCJD, initially
transmitted by BSE, display PrPres prominently in lymphoid
tissues.
To understand the spread of infectious material, host genetic
susceptibility and the pathogenesis of CWD, we generated a tg
mouse model (Meade-White et al., 2007). Here we report the
utilization of such tg mice to study infectivity, spread and
disease following oral inoculation with CWD brain. After
infection, mice homologous for the deer PrP gene remain
healthy up to 300 days but show expression of PrPres by both
western blot and immunohistochemistry in the tongue, gut,
spleen, olfactory bulb and brain stem, but not in the cerebellum,
cerebral cortex or hippocampus. After 350 days clinical disease
occurs and is associated with both PrPres deposits and
spongiform patterns classic of scrapie disease throughout the
cerebellum, cerebral cortex, entorhinal cortex and hippocam-
pus. Progression of clinical signs of ataxia, tremor, lethargy and
weakness leads to marked disease usually by 380 to 410 days
post-infection. At this time the brain displays histopathologic
evidence of advanced spongiosis, pyknotic neurons, neuronal
drop out, florid plaques and astrogliosis.Results
Generation and phenotyping of deer PrP tg mice
Reports that deer PrP allelic variation correlated with
susceptibility of deer to natural disease suggested a greater
susceptibility with glycine instead of a serine at residue 96 of
deer PrP and a serine instead of a phenylalanine at position 225
(Jewell et al., 2005; Johnson et al., 2006; O'Rourke et al., 2004)
lead to the construction of a plasmid containing deer PrP 96 gly/
225 ser under transcriptional control of murine PrP (Meade-
White et al., 2007). The resultant DNA fragment was inoculated
into fertilized eggs from PrP ko mice (129/Ola back-crossed to
C57Bl/6 mice for over six generations) at The Scripps Research
Institute transgenic facility. Eggs were then transplanted into
pseudo-ovulating foster mothers using standard techniques
(Race et al., 1995; Trifilo et al., 2006). Due to the low efficiency
employing eggs from PrP ko donors, 642 eggs were
transplanted which yielded 14 founder mice, an efficiency
slightly over 2% as compared to the usual efficiency of 20 to
30% processing eggs from C57Bl/6 mouse donors. Of the 14
founder mice, two were selected, numbers 33 and 39, to
generate lines for subsequent studies because first, they passed
the transgene with an expression level roughly equivalent to that
of murine PrP in C57Bl/6 mice and, second, bred robustly.
Initial we bred heterologous mice (±) by crossing line 33 or line
39 to PrP ko mice. Thereafter homologous (+/+) breeding was
done.
Phenotyping to judge the utility of the two deer PrP tg lines
was accomplished by inoculating heterologous tg mice from
both lines 33 and 39 intracerebrally (i.c.) with a 2% cleared
brain homogenate from a pool of CWD (Meade-White et al.,
2007) (pool 2). As shown in Table 1, both lines 33 and 39
developed disease with a mean incubation time for line 33 of
312+32 days and for line 39 of 275+46 days. Clinically ill
mice displayed ataxia, tremors, reduced movement, kyphosis
and leg weakness which was first detected at day 225 in some
mice with continuous progression involving all mice until
severity of disease required sacrifice. When homologous mice
were used these signs appeared approximately 70 days earlier.
Histologic examination of brains of severely ill mice displayed
classic spongiosis, neuronal drop out and gliosis, similar to but
in several mice more intense than the picture usually observed
with other TSE diseases. Immunohistochemistry revealed
deposition of PrPres but staining with either Thioflavin-S or
Congo red failed to document amyloid positive plaques.
Western blots, as shown in Fig. 1, documented the conversion
of deer PrPsen to deer PrPres. PrPres was glycosylated with
diglycosylated PrPres as the predominant species, although the
nonglycosylated form was also present. The glycosylated
pattern varied among individual mice studied similar to
observations for CWD infected deer and elk (Race et al.,
2002). By contrast, neither heterologous nor homologous line
33 or 39 deer PrP tg mice when inoculated with diluent of sterile
phosphate buffered saline free of CWD brain or either non-tg
C57Bl/6 mice or PrP ko mice inoculated with pooled CWD
brain developed disease or showed conversion of deer PrPsen to
Fig. 1. Detection of PrPres deposits in CWD-infected deer PrP tg mice by
Western blot. Panel A shows the presence of PrPres in brain tissue after i.c.
inoculation of CWD brain. Data from clinically ill tg± mice from lines 33 or 39
are displayed in lanes 2–4. Similar results were obtained from over 10 additional
ill CWD-infected tg mice from lines 33 and 39 at 280 to 310 dpi. Lane 1 shows
Western blot in the absence of protease K treatment (−) while all the remaining
lanes were blots with materials treated with proteinase K (25 μg/ml) (+).
Negative (neg) control was ±tg mouse inoculated i.c. with PBS diluent and
sacrificed 400 dpi while the positive (pos) control was a C57Bl/6 mouse
inoculated i.c. with murine scrapie and sacrificed at 155 dpi. PrP material was
detected with monoclonal antibody D13. Panel B displays PrPres within the
brain (br), spleen (spl), kidney (kid), pancreas (pan) and heart (hrt) of orally
inoculated tg+/+ mice at 370 dpi using monoclonal antibody D13. Spl, kid, pan
and hrt are from mouse line 39 whose br is also shown. Similar results for all
these tissues were obtained from six additional CWD-infected mice, three from
tg33+/+ and three from tg39+/+ strains. Brain homogenate from clinically ill
CWD-infected tg+/+ mice (pos) inoculated i.c. is shown for comparison. Panel
C shows PrPres deposits within the brain (br), intestine (int) and tongue (ton) of
several individual tg+/+ mice infected orally with CWD. Detection was with
monoclonal antibody L42. Similar to D13 antibody, L42 antibody failed to
detect PrPres in kid, pan or hrt (not shown) but in contrast to D13 antibody
detected PrPres in ton and int. The first two lanes on the left show the absence
(−) or presence (+) of protease K (25 μg/ml) digestion of deer PrP tg mouse
brain (br) inoculated with murine scrapie (neg control). The remainder of the
lanes are from protease K (25 μg/ml) digestions of tissues from deer PrP tg mice
infected orally with CWD.
Table 1
Clinical disease following inoculation of CWD brain into deer PrP tg mice a
Inoculate Route of
inoculation
Recipient
mice
Infected
mice total b
Mean±SD when mice
were sacrificed
CWD brain i.c. PrPko 0/5 z700
±line 33 13/13 312+ 32
±line 39 15/15 275+46
+/+line 39 5/5 210+15
C57Bl/6 0/6 z500
PBS i.c. PrPko 0/5 z600
±line 33 0/4 z600
±line 39 0/4 z600
+/+line 39 0/4 z600
C57Bl/6 0/4 z600
CWD brain Oral PrPko 0/5 z600
+/+line 33 3/3 381+55
+/+line 39 9/9 370+26
C57Bl/6 0/4 z600
PBS Oral PrPko 0/2 z640
+/+line 33 0/2 z640
+/+line 39 0/2 z640
C57Bl/6 0/2 z640
a PrPko, heterozygous (±) or homozygous (+/+) deer PrP tg, or C57Bl/6 mice
were inoculated i.c. or orally with homogenate made from pooled brains
obtained from mule deer dying from CWD. Recipient mice were followed for
signs of disease that included ataxia, tremors, weakness, lethargy and kyphosis.
b Numbers of mice having clinical signs and on sacrifice showing PrPres by
both Western blot and immunohistochemistry over the total inoculated. Those
not showing clinical signs (PrPko and C57Bl/6 mice) were sacrificed at times
indicated. Mice displaying clinical signs were sacrificed either early in disease or
when moribund.
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indicated that lines 33 and 39 expressing deer PrP with a
glycine at position 96 and a serine at position 225 were
susceptible to CWD brain challenge and were suitable for oral
transmission experiments.
Oral transmission of CWD brain to deer PrP tg mice
Oral transmission was studied in homologous deer PrP tg
lines 33 and 39 mice. Such mice received by nasal gastric tube
100 λ of a 5% brain homogenate first clarified by low-speed
centrifugation. We used the same CWD brain pool as that
employed for i.c. inoculations and performed i.c. inoculations as
positive controls. All mice given CWD brain orally developed
clinical signs of ataxia, lethargy, tremors and weakness,
between 347 and 400 days post-inoculation. These signs similar
to those present in the i.c. inoculated mice were, however,
slower to appear and lasted longer in mice inoculated orally.
Nevertheless, over time, disease progressed relentlessly leading
to sacrifice of ill mice. As shown in Table 1, mean incubation
time for disease was 381+55 days for line 33 and 370+26 for
line 39.
Study of brains from both lines showed PrPres by both
western blot (Fig. 1) and immunohistochemistry (Figs. 2C–E).
Figs. 2A and B displays the spongiosis seen in the deer PrP tg
mice infected orally with CWD brain and sacrificed early in the
course of clinical disease. In addition, activation of astrocytes
(gliosis) was observed. Fig. 2E shows activated processes from
astrocytes surrounding a PrPres plaque. Such PrPres plaqueswere common and located in the olfactory bulb, entorhinal
cortex, cerebral cortex, hippocampus, limbic system and
cerebellar areas. As with the i.c. inoculation there was no
evidence of amyloid deposits using Thioflavin-S or Congo red
staining. As a positive control to detect amyloid, brain sections
from murine scrapie infected tg mice that expressed the
anchorless form of PrP and abundantly deposited Thioflavin-S
or Congo red staining amyloid were used (Chesebro et al., 2005;
Trifilo et al., 2006). Our inability to find amyloid in i.c. or orally
inoculated deer PrP tg mice that develop disease contrasts with
Fig. 2. Analysis of CNS tissues from deer PrP tg+/+ mice given CWD brain orally. Presence of spongiform lesions characteristic of TSE lesion in the hippocampus is
shown in panel A and cerebellum in panel B. H&E staining was used and mice were sacrificed at 340 dpi. Panel C shows deposition of PrPres within the frontal cortex
at 370 dpi and panel D in the cerebellum at 320 dpi. D13 monoclonal antibody was used to detect PrPres for immunohistochemical analysis. Panel E displays double-
immunochemical staining of an area in the cortex displaying astrocytic processes with antibody to GFAP (red) that surround a PrPres plaque (greenish/blue) stained
with D13 antibody. Mouse sacrificed at 380 dpi. Panel F shows the absence of disease in cerebellum of deer PrP tg mouse inoculated with PBS diluent and sacrificed
400 dpi. Neither gliosis nor PrPres staining occurred in similar mice or in deer PrP tg mice inoculated with murine scrapie or non-tg mice inoculated with CWD.
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(Browning et al., 2004; Guiroy et al., 1991; Sigurdson et al.,
2006; Tamguney et al., 2006). A few mice sacrificed later when
clinical disease was severe showed massive amounts of
spongiosis, neuronal loss and gliosis throughout the brain.
Remarkable was the susceptibility of granular cells in the
olfactory bulb, hippocampus and cerebellum along with
destruction of neurons and structure in the limbic system,
cerebellum, entorhinal cortex and cerebral cortex often asso-
ciated with enlargement of the lateral ventricle. Again, neither
histologic disease nor conversion of deer PrPsen to deer PrPres
occurred either in deer PrP tg mice inoculated with murine
scrapie or deer PrP tg mice inoculated with the PBS diluent
(Table 1; Figs. 1 and 2F).
Study of peripheral tissues revealed deer PrPres in the spleen,
intestinal tract, oral cavity and tongue (Figs. 1 and 3) but not in
pancreas, heart, liver, thymus, lung or skeletal muscle. Fordetection of PrPres by western blot (Fig. 1), we used both
monoclonal antibodies D13 and L42 (Chesebro et al., 2005;
Meade-White et al., 2007; Trifilo et al., 2006). For this assay L42
has a 10- to 15-fold higher affinity for detection of deer PrPres
than does D13. However, for immunohistochemistry we
employed D13 as L42 reacted poorly displaying unsatisfactory
background noise. In the spleen, the majority of PrPres staining
was within large cells surrounding the B and T zones, likely
macrophages and/or dendritic cells according to their location
and size (Fig. 3). Institutional biosafety concerns disallowed
segregating and staining such cells for FACS analysis and thus a
more precise definition of the cell(s) containing PrPres. Also, as
shown in Fig. 3, PrPres was identified immunohistologically on
the posterior surface of the dorsum of the tongue, localized
primarily to serous and mucosa glands (Figs. 3A and C).
Double-staining with antibodies to detect PrPres and neuronal
cell body and their processes did not colocalize the PrPres
Fig. 3. Analysis of peripheral tissues from deer PrP tg+/+ mice given CWD brain
orally. Panels A and C (insert from panel A) are from the tongue of a mouse
sacrificed 380 dpi. Serous and mucous glands in the posterior part of the dorsum
of the tongue contain PrPres material detected with D13 antibody. Staining of
same or adjacent section with monoclonal antibody to neuron-specific nuclear
protein NeuN or with antibody to neurofilament H failed to show colocalization
to PrPres (data not shown). This observation was confirmed in five additional
deer PrP tg mice infected orally with deer PrP. Age-matched tongue specimens
from deer PrP tg mice infected with murine scrapie or inoculated with PBS
diluent or from C57Bl/6 mice inoculated with CWD brain were all negative
(n=5 or more/group). Panels B and D (insert of panel B) are from the spleen.
Panel D shows PrPres deposits in large cells, likely macrophage and/or dendritic
cells, around splenic granule.
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neuronal cells. Occasionally the taste buds were noted to contain
PrPres. In the intestinal track PrPres was noted in Peyer's
patches and neuronal ganglion cells in the lower intestinal track.
In contrast, PrPres deposits were not found in these tissues when
studying either PBS inoculated deer PrP tg mice (n=8), CWD
brain inoculated C57Bl/6 mice (n=6) or in PrP ko mice (n=5)
when observed for up to 600 days post-inoculation.Table 2
PrPres distribution following oral infection of deer PrP+/+ tg mice with CWD brain
Sacrifice
date
Clinical
signs
Mouse
#
Non-neuronal tissues
Tongue Spleen Lung Liver Heart In
200–300 dpi No 1 ++ ++ Nil Nil Nil ++
No 2 ++ ++ Nil Nil Nil ++
No 3 ++ Nil Nil Nil Nil N
350–410 dpi Yes 1 ++ ++ Nil Nil Nil ++
Yes 2 ++ ++ Nil Nil Nil ++
Yes 3 ++ ++ Nil Nil Nil ++
a Mice were inoculated orally with a 5% brain homogenate stock made from mule d
paraformaldehyde and processed for immunohistochemistry.Kinetics of deer PrPres expression in deer PrP tg mice
following oral inoculation with CWD brain
The last series of studies compared deer PrP tg mice after
oral inoculation with CWD brain for the expression of PrPres at
day 200 to 300 when such mice were clinically asymptomatic
with similarly inoculated littermates at 350 to 410 days when
overt signs of disease occurred. Table 2 shows results of mice
from line 39 which was similar to those observed with line 33.
All mice analyzed when clinically well displayed PrPres in the
tongue and spleen, while two of three also possessed PrPres in
the lower intestine, brain stem and olfactory bulb, but not in the
cerebellum, cerebral cortex or hippocampus. Mice with clinical
signs of disease retained PrPres expression in the tongue,
spleen, intestine, olfactory bulb and brain stem but, in contrast,
now showed abundant PrPres in the cerebellum, cerebral cortex,
entorhinal cortex and hippocampus. PrPres did not occur in
lung, liver or heart.
Discussion
Here we record a murine tg model of CWD in which deer
scrapie is transmitted orally, thus mimicking the suspected
natural transmission route of this TSE disease. Although several
murine tg models of CWD have been reported (Browning et al.,
2004; LaFauci et al., 2006; Sigurdson et al., 2006; Tamguney
et al., 2006) they described transmission by the i.c. route while
to our knowledge this is the first description of CWD disease
transmitted by the oral route.
Recently Mathiason (Mathiason et al., 2006) reported that
saliva and blood of deer with CWD transmitted infectivity when
transferred i.c. or transfused i.v. to naive deer. In our tg model
we noted that prior to and during clinical disease serous and
mucous glands found in the dorsum of the tongue which
produce saliva contained PrPres. These findings both support
and extend the findings of Mathiason (Mathiason et al., 2006) in
deer and indicate the utility of the murine tg model for more
detailed and complex studies in pathogenesis and for studies of
transmission which are difficult to do in deer due to size and
housing, experimental numbers required and cost. We have
initiated studies to test the transmission of CWD in orally
inoculated tg mice through saliva by biting or via shared water
supply. Further, our finding that following oral ingestion ofa
Neuronal tissues
testine Olfactory bulb Brain stem Cerebellum Cortex Hippocampus
++ ++ Nil Nil Nil
++ ++ Nil Nil Nil
il Nil Nil Nil Nil Nil
++ ++ ++ ++ ++
++ ++ ++ ++ ++
++ ++ ++ ++ ++
eer dying of CWD. Neural and non-neural tissues were isolated and stored in 4%
2 Williams, E., Jewell, J. Unpublished observations.
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the brain in a near symmetrical pattern that would follow blood
supply to that organ suggests that spread of infection is unlikely
via the circulation. This conclusion is further strengthened by
not finding evidence of PrPres in or around blood vessels or in
the heart or kidney. The initial expression of PrPres in the CNS
occurs in the brain stem and olfactory bulb and not in the
cerebellum, cerebral cortex or hippocampus suggesting early
transmission to the CNS is likely via nerves connecting the oral
cavity and gut to the CNS (Sigurdson et al., 2001).
The distribution of spongiosis, gliosis and PrPres although
earliest in the olfactory bulb and brain stem, progressed over
time to involve dramatically the cerebral cortex, entorhinal
cortex, olfactory bulb, cerebellum, hippocampus and limbic
system. Although neuronal injury was observed throughout, the
susceptibility of granular cells at several sites, i.e., olfactory
bulb, hippocampus and cerebellum was remarkable. At end
stage, brains analyzed after i.c. or oral inoculations were
generally indistinguishable from each other. While florid
plaques were easily observed, we failed to detect, by either
Thioflavin-S or Congo red staining, amyloid deposits. Why
amyloid fibrils failed to occur in our tg mouse model despite the
heavy accumulation of PrPres is not presently known. However,
in our model such insoluble amyloid protein aggregates are not
required for tissue destruction and disease.
The finding of PrPres in spleen and lymph nodes of deer PrP
tg mice following oral inoculation of CWD brain mimics what
has been reported in deer developing CWD either through
natural or experimental infection (Fox et al., 2006; Sigurdson
et al., 1999, 2002). We were not able to identify with precision
those lymphoid cells that contain PrPres. Nevertheless, anatomic
study of the spleen strongly suggested that PrPres was contained
in macrophages and/or dendritic cells, cells that have been
previously identified as infected by scrapie in other systems
(Brown et al., 1999; Heikenwalder et al., 2004).
In addition to the study of pathogenesis, the deer PrP tgmodel
will be a valuable bioassay tool to investigate select PrP
polymorphism of residues 96 and 225, to determine whether or
not there are unique deer scrapie strains, to determine what
materials in TSE deer carry infectious material and to quantitate
the amounts of infectivity found in materials transmitting
infection.
In collaboration with Chesebro's group (Meade-White et al.,
2007), it was recently noted that deer PrP tg mice expressing
glycine at residue 96 were significantly more susceptible to
infection and disease after CWD brain inoculation than deer PrP
tg mice expressing a serine at this position. These findings in tg
mice support suggestive field epidemiologic findings with
several deer populations (Johnson et al., 2006; Miller and
Williams, 2004; O'Rourke et al., 2004) and suggest that
genotyping and selecting deer with serine 96 for commercial
breeding might result in a deer population more resistant to
CWD.
Finally, utilizing deer PrP glycine 96/serine 225 tg mice we
have inoculated urine, feces, blood, white and red blood cells,
serum and saliva obtained from six distinct cases of deer with
CWD. Samples were collected kinetically at 3 or 6 monthintervals from onset of experimental inoculation of deer with
CWD until clinical illness.2 At the time of autopsy such samples
as well as lymph nodes, spleens and brains harvested from these
deer were also collected and inoculated into our tg mice.
Currently at over 250 days of observation, none of our deer PrP
tg mice has shown signs of CWD disease. Western blots of
brains from two deer PrP tg mice sacrificed 140 days after
receiving saliva from deer with CWD have not shown
conversion of deer PrPres from deer PrPsen while lymph node
from the same deer inoculated into PrP tg mice have. These
ongoing observations should provide leads into detecting when
and which samples contain infectious material, point to those
samples that should be titered to quantitate amounts of
infectivity, offer insights following time of incubation to illness
for location of PrPres, better our understanding of pathogenes
and determine whether there may be distinct strains of CWD as
has been observed in other TSE diseases.
Materials and methods
Generation and genotyping of deer PrP tg mice
DNA encoding the half genomic mouse PrP was modified to
encode the deer PrP gene with glycine at residue 96 and a serine
residue 225 as described (Meade-White et al., 2007). This
construct was inoculated into eggs obtained from PrP ko mice.
Inoculated eggs were transplanted in pseudo-ovulated C57Bl/6
mothers (Chesebro et al., 2005; Trifilo et al., 2006). DNA
obtained from tail biopsy of pups was analyzed to select
founders and establish lines using the following primers:
CWD 2U 5′ ACC AAA ACC TGG AGG AGG A 3′
CWD 4L 5′ TCG CTC CAT CAT CTT GAT GTC A 3′
Scrapie materials, mouse strains and inoculations
Two sources of TSE infectivity were used. First, a pool of six
CWD brain isolates from free-ranging mule deer was obtained
by Dr. Elizabeth Williams, Department of Veterinary Science,
University of Wyoming, Laramie, Wyoming (Meade-White
et al., 2007) (pool 2) and supplied by Rick Race, Laboratory of
Persistent Viral Diseases, Rocky Mountain Laboratory, NIAID,
NIH, Hamilton, Montana, and second, the RML (Chandler
strain) murine scrapie was originally obtained from Rick Race,
Laboratory of Persistent Viral Diseases, Rocky Mountain
Laboratory, NIAID, NIH, Hamilton, Montana. The RML
scrapie brain material has been maintained at Scripps by i.c.
passage using C57Bl/6 mice. Six-to 8-week-old mice received
either 30 λ of a 2% or 5% low-speed centrifugation cleared
brain homogenate administered i.c. through the skull in the
fronto-parietal region of the brain using a 27 gauge needle or
100 μl of a 5% low-speed centrifuge cleared brain homogenate
given orally via a flexible polypropylene catheter inserted over
the tongue about 1 to 2 cm into the esophagus (Race et al., 2000;
Trifilo et al., 2006). Mice used were bred and handled at The
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and NIH guidelines. Employed were C57Bl/6 mice, PrP ko
mice and deer PrP tg mice bred onto C57Bl/6 background.
Inoculated mice were observed daily for signs of clinical disease
that included lethargy, tremors, ataxia, weakness and kyphosis.
Histologic and Western blot analysis
Tissue collected was immediately either fixed in neutral
buffered 4% formaldehyde for 3 to 5 days or stored at
−80 °C until used. Tissues fixed in 4% formaldehyde solution
were dehydrated, embedded in paraffin, cut into 4 to 5 μ
sections and placed on glass slides. Histologic examination
utilized hematoxylin and eosin stain. Immunohistochemical
staining was performed as described (Chesebro et al., 2005;
Trifilo et al., 2006). Briefly, slides were deparaffinized and
rehydrated in xylene, alcohol, PBS rinses and autoclaved for
15 min at 20 psi/120 °C for retrieval of antigen. Samples
were then blocked in 2% BSA and stained for PrPres using
either 3 μg/ml of D13 monoclonal antibody (Chesebro et al.,
2005; Trifilo et al., 2006), astrocyte activation using a 1:200
dilution of rabbit antibody to glial fibrillary acid protein
(GFAP) (Dako Cytomation, Denmark) or neuronal markers
using monoclonal antibody to neuronal nuclei (NeuN) and
rabbit anti-neurofilament H antibody (both from Chemicon
International, USA, and used according to the manufacturer's
recommendations). After an overnight incubation at 4 °C,
slides were rinsed with buffer and stained with the appropriate
secondary biotinylated goat anti-human (for D 13), goat anti-
rabbit (for GFAP and neurofilament H) or goat anti-mouse
(NeuN) antibody. Streptavidin conjugated rhodamine or
fluorescence or horseradish peroxidase (HRP) followed by
ventana aminoethylcarbazol. Thioflavin S and Congo red
staining was done as reported (Chesebro et al., 2005; Trifilo
et al., 2006). Microscopy was performed with an Axiovert
S100 Zeiss microscope.
For Western blot analysis, individual tissues selected for
study were placed separately into 2 ml polypropylene screw cap
tubes, filled up to 25% with sterilized glass beads (1.0 mm
diameter beads from Biospec Products, Inc., Bartlesville, OK)
containing 1 ml sterile 0.01M Tris–HCl, pH 7.4, with 0.005 M
MgCl2. Tubes were placed into the Mini Beadbeater 8 (Biospec)
and homogenized for 1 min. Homogenates were transferred to
sterile 1.5 ml Eppendorf tubes and incubated with DNase
(RNase-free DNase I; Roche Diagnostics, Indianapolis, IN;
1 mg/g starting tissue) for 1 h at 37 °C. Samples were then
transferred to polyallomer Bell-top Quick Seal centrifuge tubes
and an equal volume of 20% Sarkosyl in Tris–HCl were buffer
added. The suspension was vortexed, incubated for 1 h at room
temperature and topped off with 10% Sarkosyl (final volume,
3.5 ml per tube). Tissue homogenate samples were clarified by
centrifugation at 10,000×g for 30 min at 10 °C; the supernatant
was collected and centrifuged at 70,000×g for 2 h at 10 °C in a
Beckman TL-100 Ultracentrifuge with a TLA 100.3 rotor. The
resultant pellet was resuspended in 1 ml of sterile water (1 ml/
200 mg starting tissue), sonicated until disrupted in a Sonic
Dismembrator 60, setting 1 (Fisher Scientific, Pittsburgh, PA)and digested with Proteinase K, 25 μg/ml (Roche Diagnostics,
Indianapolis, IN) for 30 min at 37 °C. The reaction was stopped
by addition of 0.1 M phenylmethylsulfonylfluoride (PMSF) and
cooling on ice for 15 min. After centrifugation at 70,000×g for
1 h at 10 °C, pellets were resuspended in 25 μl sample buffer,
sonicated, boiled for 5 min and run on SDS-PAGE gels
(Chesebro et al., 2005; Trifilo et al., 2006). Gels were blotted
onto PVDF membranes (Invitrogen, Carlsbad, CA) and blocked
for 1 h at room temperature in 5% powdered skim milk in sterile
water. PrPres bands were detected by adding anti-PrP mono-
clonal antibody D13 (3 μg/ml) or anti-PrP monoclonal antibody
L42 (180 ng/ml) (Chesebro et al., 2005; Trifilo et al., 2006) to
membranes and incubating overnight at 4 °C. Membranes were
rinsed with buffer and stained with a HRP-conjugated goat anti-
human antiserum for detection of D13 antibody or HRP-coated
sheep anti-mouse antibody. Bands were identified with either
the Pico or Phemto chemiluminescent detection kit (Pierce
Biotechnology, Rockford, IL) (Trifilo et al., 2006).
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